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Lymphopenia Association with Planning Target Volume and Lung V5 and its Effect 
on Survival of Esophageal Cancer receiving Neoadjuvant Chemo-radiation with 
Dutch CROSS Regime 
 
Intro 
Radiation has a strong lympholytic effect. This effect has been overlooked for 
decades until recently. As immunotherapy is becoming one of the main systemic 
treatment of various cancer, it is important to adopt best radiation technique to 
preserve lymphocyte numbers.  
Radiation-induced lymphopenia has been reported to be adversely associated with 
overall survival and recurrence free survival in various cancers including lung, 
pancreatic and head and neck cancer.  Data of lymphopenia effect on esophageal 
cancer is lacking.  We therefore sought to study the association of lymphopenia and 
overall survival in esophageal cancer patients who have undergone neoadjuvant 
chemo-radiation according to Dutch CROSS trial regime.  
One of the possible mechanism of severe lymphopenia in radiotherapy is the large 
volume of low dose bath killing large number of circulating lymphocytes in both 
systemic and pulmonary circulation. As there is report of relationship of low dose 
lung dosimetry parameters with lymphopenia in NSCLC, we also aim to study this 
relationship in esophageal cancer. 
 
method 
All esophageal cancer patients from June 2012 to April 2015 in our tertiary university 
hospital who have received neoadjuvant chemo-radiation according to Dutch CROSS 
trial regime has been retrospectively reviewed. Total subjects eligible for review is 51. 
One subject has died before the start of chemo-radiation and thus was excluded 
from analysis.  
Lymphocyte nadir was defined as the minimum lymphocyte 
value measured between the start of neoadjuvant chemo-radiation and the 
operation date.   
Relationships between lymphocyte nadirs with overall survival (OS) and recurrence 
free survival (RFS) were evaluated with Cox-regression analysis. Association between 
Planning Target volume (PTV) and lung dose- volume histogram (DVH) parameters 
were analysed with multivariable linear regression. 
 
Results 
Median OS for this group is 446 days (14.9months). 48 out of 50 subjects have 
normal baseline lymphocyte counts. Low lymphocyte nadir is found to have negative 
effect on patient's overall survival (OS) and recurrence-free survival (RFS) even after 
adjustment with PTV volume. 
PTV volume, in contrast to common belief, has no statistical significant effect on both 
OS and DFS.  Baseline total white cell count, neutrophil and lymphocyte count are 
not correlated with survival neither. 
Analyses of lung DVH parameters revealed significant linear regression coefficient 
from -0.4 to -0.8 at low dose zone V1-V15 with lymphocyte nadir  (P<0.05). 
Comparing patients treated with 3D conformal and IMRT technique, there are no 
statistical significant difference  by Mann-Whitney U tests in lung DVH, lymphocyte 
nadir , RFS and OS (P> 0.3). 
 
conclusion 
Lower lymphocyte nadir is associated with poorer overall survival in this group of 
patients. Higher low dose lung DVH and larger PTV are associated with lower 
lymphocyte nadir, in both 3D conformal  and IMRT techniques. These findings shall 
be confirmed with prospective data in future studies. This also suggests immune 
preserving radiation strategy in radiation by suppressing low dose lung DVH may 
improve OS in this group of patients 
 
 
